Pay in 4 interest-free payments of $6.88 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
In expanded populations, comparing semaglutide versus sitagliptin for the composite outcome of myocardial infarction or stroke yielded a hazard ratio of 0.82 (95% confidence interval (CI) 0.74 to 0.91), and comparing tirzepatide versus dulaglutide for the composite outcome including mortality yielded a hazard ratio of 0.87 (95% CI 0.75 to 1.01)
Pharmacological treatment of obesity in older adults
The 50mg vial is the common entry size
In Proceedings of the Clinical Trials on Alzheimers Disease (CTAD) (Oral Presentation, San Diego, CA, USA, 2025)
US$ 25.19
US$ 24.04
US$ 29.28
